Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice
NCT ID: NCT03604081
Last Updated: 2020-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-06-11
2020-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strengthening in Sub-acute Stroke Survivors: A Randomized Controlled Trial
NCT06140381
Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation
NCT06637839
Modified Constrained - Induced Movement Therapy Compared to Intensive Bimanual Training
NCT00851123
Peer Group Regulated mCIMT Program for Adult Stroke Patients: Effects on Functional Activities
NCT04264195
Constraint-induced Movement Therapy to Improve Gait and Mobility of People With Chronic Stroke
NCT03114046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
One hour of intense massed practice of lower extremity either in the form of shaping or task practice
CIMT
Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice.
Control Group
Conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline.
Conventional Physical Therapy
1 hour as per current standard of care that follows stroke clinical practice guideline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CIMT
Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice.
Conventional Physical Therapy
1 hour as per current standard of care that follows stroke clinical practice guideline.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* new ischemic stroke as revealed by CT scan or MRI of a brain or as per updated definition by American heart and American stroke association (Sacco et al., 2013)
* Manual muscle testing with grad of \> 1+ in hip and knee joint musculature
* able to walk atleast 10 feet indoors with or without assistance and assistive device.
* Motivated to participate and some initiation of flexion and extension movement in hip, knee and ankle joints.
* Ability to follow visual/verbal instructions as assessed by a minimum score of 24/30 points on the minimental state examination
* Fairly intact sensation
Exclusion Criteria
* Severe joint pain or degenerative disease to the musculoskeletal system of the lower extremity
* other neurological disease 4) problems with following instructions.
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nada Abou-Fayssal, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-00773
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.